Is the prescription right? A review of non-vitamin K antagonist anticoagulant (NOAC) prescriptions in patients with non-valvular atrial fibrillation. Safe prescribing in atrial fibrillation and evaluation of non-vitamin K oral anticoagulants in stroke prevention (SAFE-NOACS) group.
Rebabonye B PharithiDeepti RanganathanJim O'BrienEmmanuel E EgomCathie BurkeDaniel RyanChristine McAuliffeMarguerite VaughanTara CoughlanEdwina MorrisseyJohn McHughDavid MooreRonan CollinsPublished in: Irish journal of medical science (2018)
Our study highlights significant inaccuracies in NOAC prescribing. Patients commenced on NOACs should be assessed and followed up in a multidisciplinary AF clinic to ensure safe and effective prescribing and stroke prevention.
Keyphrases
- oral anticoagulants
- atrial fibrillation
- primary care
- left atrial
- catheter ablation
- left atrial appendage
- direct oral anticoagulants
- heart failure
- end stage renal disease
- percutaneous coronary intervention
- ejection fraction
- chronic kidney disease
- newly diagnosed
- adverse drug
- prognostic factors
- emergency department
- venous thromboembolism
- brain injury
- drug induced